MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Japan
2016-139495
Filed on 2016-07-14
2016-139495
Filed on 2016-07-14
MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)
United Kingdom
07867402.5
Filed on 2007-11-01
07867402.5
Filed on 2007-11-01
MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)
Switzerland
07867402.5
Filed on 2007-11-01
07867402.5
Filed on 2007-11-01
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
Italy
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
United Kingdom
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
France
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
Switzerland
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE
Italy
08768266.2
Filed on 2008-06-09
08768266.2
Filed on 2008-06-09